Home Health Care Progenics, Regeneron announce positive product news

Progenics, Regeneron announce positive product news

SHARE

Regeneron announces positive study results for a sinus drug, and Progenics’ drug Relistor gains another approved use by the U.S. Food and Drug Administration.

This content is for Westfair Online members only. Please to view this content. Become a member by Registering Here.
Print Friendly, PDF & Email